eli lilly retatrutide study stock jumps on Phase 3 weight loss results retatrutide expanded access program eli

Diabetes Care 31(5):845851

When to consider a dose increase A genuine plateau means weight loss has stopped for at least 3-4 consecutive weeks despite consistent dosing, adherence to a moderate caloric deficit, and no changes in medication or health status that could explain the stall

Ultimately, this means that Semaglutide reduces hunger, slows gastric emptying, and promotes a feeling of fullness making it a highly effective tool for weight loss, without feeling like youre depriving yourself of food

The lowest dose of tirzepatide (5 mg) offered similar reductions from baseline in HbA1c and body weight versus the highest dose of semaglutide (2 mg)

Retatrutide is being studied as a triple agonist that targets GLP-1, GIP, and glucagon pathways

Direct-to-consumer marketing by telehealth platforms and compounding pharmacies has fueled demand for compounded GLP-1 therapies, promoted as affordable and personalized alternatives